Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 7Unknown 3Terminated 3Active not recruiting 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

penpulimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Advanced Malignant Neoplasm × Clear all
NCT06297642 2024-08-06

TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Terminated
3 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT03049397 2021-11-17

Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer

Fred Hutchinson Cancer Center

Phase NA Terminated
15 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT03051035 2021-09-20

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Kura Oncology, Inc.

Phase 1 Terminated
61 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡